Selegiline Hydrochloride
9 NDCs across 5 manufacturers|8 Generic,1 Brand
Selegiline Hydrochloride is used to treat alzheimer disease, attention deficit disorder with hyperactivity, depressive disorder, parkinson disease and schizophrenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 5, 1989, and the first generic was approved Aug 2, 1996. FDA's Orange Book lists 5 AB-rated (therapeutically equivalent) products for this ingredient.
Selegiline Hydrochloride is available as 9 NDCs from 5 manufacturers (8 generic, 1 brand), with NADAC prices from $0.61 to $66.61 per EA — the most expensive product costs about 109× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
8G / 1B
Manufacturers
5
competing in market
Price Spread
$0.61 – $66.61
per EA
7d Activity
avg +1.2% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Apotex Corp. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Monoamine Oxidase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing SELEGILINE HYDROCHLORIDE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZELAPAR 1.25 MG ODT TABLET | $66.6094 per EA | — |
SELEGILINE HCL 5 MG TABLET | $0.7657 per EA | -3.39% |
SELEGILINE HCL 5 MG TABLET | $0.7657 per EA | -3.39% |
SELEGILINE HCL 5 MG CAPSULE | $0.7563 per EA | +3.50% |
SELEGILINE HCL 5 MG CAPSULE | $0.7563 per EA | +3.50% |
SELEGILINE HCL 5 MG CAPSULE | $0.7563 per EA | +3.50% |
SELEGILINE HCL 5 MG CAPSULE | $0.7563 per EA | +3.50% |
SELEGILINE HCL 5 MG CAPSULE | $0.7307 per EA | — |
SELEGILINE HCL 5 MG TABLET | $0.6101 per EA | — |
Frequently Asked Questions
What is Selegiline Hydrochloride used to treat?
Selegiline Hydrochloride is used to treat alzheimer disease, attention deficit disorder with hyperactivity, depressive disorder, parkinson disease and schizophrenia, per the National Library of Medicine's MED-RT classification.
When did Selegiline Hydrochloride become available as a generic?
FDA approved the first generic Selegiline Hydrochloride (ANDA) on Aug 2, 1996. The Orange Book currently lists 5 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Selegiline Hydrochloride products are on the market?
The Selegiline Hydrochloride drug market contains 9 NDCs from 5 manufacturers — 8 generic and 1 brand product.
What is the price range for Selegiline Hydrochloride?
NADAC reference prices for Selegiline Hydrochloride range from $0.6101 to $66.6094 per EA — the most expensive product costs about 109× the cheapest.
Is generic Selegiline Hydrochloride cheaper than brand?
The average generic NADAC for Selegiline Hydrochloride is $0.7372 per EA, versus $66.6094 for brand-labeled products — brand versions average about 90× the generic price.
Which manufacturers make Selegiline Hydrochloride?
5 manufacturers list Selegiline Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Apotex Corp. (4), Novitium Pharma LLC (2), Bausch Health US LLC (1), i3 Pharmaceuticals, LLC (1), Rising Pharma Holdings Inc. (1).
How has the price of Selegiline Hydrochloride changed recently?
Over the past 7 days, 8 Selegiline Hydrochloride NDCs rose and 4 fell, with a market-wide average change of +1.2%.